Eurofins Scientific Nante
Eurofins Scientific Nante/ FR0014000MR3 /
ERFSF
|
2024-11-12 8:26:32 PM
|
Chg.
-0.1050
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
50.1450USD
|
-0.21%
|
17,524
Turnover: 23,098.1110 |
-Bid Size: - |
-Ask Size: - |
9.3 bill.USD |
- |
- |
Business description
Eurofins Scientific is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins believes it is a worldwide leader in its field. The Group offers a portfolio of more than 150,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Through research and development and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
Management board & Supervisory board
| CEO |
| Dr. Gilles G. Martin |
| Management board |
| Gabriel Julia, Dr. Timothy S. Oostdyk, Joachim Reichelt, Yvoine Rémy, François Vigneau, Brian Williams, Laurent Lebras, Dr. Christian Wurst, Sean Murray, Ramón Armas, Beth DiPaolo, Natalia Shuman, Gregg Tiemann |
| Supervisory board |
| Dr. Gilles Martin, Dr. Yves-Loïc Martin, Evie Roos, Fereshteh Pouchantchi, Ivo Rauh, Pascal Rakovsky, Patrizia Luchetta, Valérie Hanote |
Company data
| Name: |
Eurofins Scientific S.A. |
| Address: |
Chausée de Malines 455,B-1950 Kraainem |
| Phone: |
+32-2-766-1620 |
| Fax: |
+32-2-766-1639 |
| E-mail: |
info@eurofins.com
|
| Internet: |
www.eurofins.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
66.60% |
| IPO date: |
1997-10-24 |
Investor relations
| Name: |
- |
| IR phone: |
+32-2-769-7383 |
| IR Fax: |
- |
| IR e-mail: |
ir@eurofins.com
|
